Understanding GHK-Cu
GHK-Cu is a copper-binding peptide discussed in skin remodeling and hair research. Available evidence includes topical cosmetic research, while injectable use remains unvalidated in humans.
Peptide Type
Copper-binding peptide
Research Focus
Skin remodeling and hair-related research
Main Research Formats
Topical cosmetic products and injectable research formulations
Evidence Context
Limited topical clinical evidence, indirect reports and commercially reported cosmetic claims
Human Injection Evidence
The reported human injection regimens are not validated
Important Evidence Distinction
Topical cosmetic experience does not establish the safety or effectiveness of injectable GHK-Cu. These formulations and routes must be evaluated separately.
Reported Use Patterns
The source describes community-reported injection examples and topical cosmetic concentrations. These examples are not validated treatment recommendations.
SC example
Per administration
Frequency
Daily total
Reported cycle
Injection Example — Short Schedule
1 mg per administration
Five days per week
1 mg on reported administration days
Four weeks
Injection Example — Extended Schedule
1–2 mg per day
Daily
1–1.5 mg or 1.5–2 mg per day, depending on the reported example
4–6 weeks or 6–8 weeks
Topical Cosmetic Concentrations
1%, 2% or 3% w/w
Topical product concentration
10, 20 or 30 mg per gram of product
Not specified in source
Injection Example — Short Schedule
Per administration
1 mg per administration
Frequency
Five days per week
Daily total
1 mg on reported administration days
Reported cycle
Four weeks
Injection Example — Extended Schedule
Per administration
1–2 mg per day
Daily total
1–1.5 mg or 1.5–2 mg per day, depending on the reported example
Reported cycle
4–6 weeks or 6–8 weeks
Topical Cosmetic Concentrations
Per administration
1%, 2% or 3% w/w
Frequency
Topical product concentration
Daily total
10, 20 or 30 mg per gram of product
Reported cycle
Not specified in source
Injection examples are community-reported and do not establish a validated human regimen. Topical percentages describe product concentration, not injectable dosing.
Research Context Only
No human injection regimen is validated in the source. Topical cosmetic concentrations cannot be used to infer injectable safety or effectiveness.
Safety Considerations
GHK-Cu research requires careful distinction between topical and injectable formulations. Injection reactions and copper-handling concerns are highlighted in the source.
Storage and Monitoring
Injectable Product Stability
No universal injected-product stability period is provided. Formulation-specific documentation is required.
Copper Monitoring
Copper and ceruloplasmin are discussed as monitoring considerations.
Product Formulation
Topical products and injectable formulations must be treated as separate product formats.
Monitoring Caution
Copper disorders warrant particular caution.
Example Concentration Calculations
The following are independently recomputed concentration examples from the source. They are mathematical illustrations, not mixing or administration instructions.
Amount (mg)
Final volume (mL)
Concentration (mg/mL)
Per 1 U (mcg)
Per 10 U (mcg)
U refers to a U-100 volume marking, where 1 U = 0.01 mL. These calculations are examples only and are not mixing or administration instructions.
What Does the Research Show?
The source highlights limited topical clinical findings and notes that some cosmetic claims rely on indirect reports or company material rather than definitive clinical evidence.
Post-Laser Topical Trial
A post-laser topical trial included 13 completers.
Limited Objective Results
The trial did not show significant objective differences in wrinkle or skin-quality outcomes.
Indirect Cosmetic Evidence
Some other cosmetic claims rely on indirect reports or company material rather than definitive clinical studies.
Regulatory and Research Limitations
Injectable Use Is Not Validated
The source does not establish a validated human injection regimen for GHK-Cu. Topical cosmetic evidence cannot be used to establish injectable safety or effectiveness.
This page is for educational and research reference only. It is not medical advice or a recommendation to use GHK-Cu.
